0
Skip to Content
Healis Therapeutics
About
Contact
Research
Healis Therapeutics
About
Contact
Research
About
Contact
Research

Treatment of depression with onabotulinumtoxinA: A randomized, double-blind, placebo controlled trial

Jan 18
Written by Sebastian De Beurs
Sebastian De Beurs
Previous
Previous

Treatment of Major Depressive Disorder Using Botulinum Toxin A: A 24-Week Randomized, Double-Blind, Placebo-Controlled Study

Next
Next

Treatment of Depression with Botulinum Toxin A: A Case Series

© Healis Therapeutics, Inc. All Rights Reserved.
info@healisthera.com
245 First St, Cambridge, MA 02142